diltiazem has been researched along with landiolol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, M; Fujisawa, H; Ideguchi, M; Ishihara, H; Kajiwara, K; Kato, S; Suzuki, M; Yoshikawa, K | 1 |
| Hosoda, S; Kasanuki, H; Kitakaze, M; Namiki, A; Sakamoto, A; Takamoto, S | 1 |
| Akaishi, M | 1 |
| Arai, H; Makita, S; Miyagi, N; Nagaoka, E; Tamura, K | 1 |
2 trial(s) available for diltiazem and landiolol
| Article | Year |
|---|---|
Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiac Surgical Procedures; Cardiovascular Agents; Diltiazem; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Urea | 2012 |
Prevention of atrial fibrillation with ultra-low dose landiolol after off-pump coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass, Off-Pump; Diltiazem; Female; Hemodynamics; Humans; Incidence; Japan; Male; Middle Aged; Morpholines; Multivariate Analysis; Odds Ratio; Prospective Studies; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome; Urea | 2014 |
2 other study(ies) available for diltiazem and landiolol
| Article | Year |
|---|---|
Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center.
Topics: Adrenergic beta-Antagonists; Autonomic Nervous System Diseases; Baroreflex; Brain Stem Neoplasms; Calcium Channel Blockers; Diltiazem; Hemangioblastoma; Humans; Hypertension; Magnetic Resonance Imaging; Male; Medulla Oblongata; Morpholines; Postoperative Complications; Solitary Nucleus; Tachycardia; Urea; Vasomotor System; Young Adult | 2010 |
Intravenous infusion of ultra-short-acting β-blocker for postoperative atrial fibrillation is the one of choice.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Surgical Procedures; Cardiovascular Agents; Diltiazem; Female; Humans; Male; Morpholines; Postoperative Complications; Urea | 2012 |